389 related articles for article (PubMed ID: 1375242)
1. Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice.
Infante AJ; Levcovitz H; Gordon V; Wall KA; Thompson PA; Krolick KA
J Immunol; 1992 Jun; 148(11):3385-90. PubMed ID: 1375242
[TBL] [Abstract][Full Text] [Related]
2. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes.
Infante AJ; Thompson PA; Krolick KA; Wall KA
J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927
[TBL] [Abstract][Full Text] [Related]
3. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
[TBL] [Abstract][Full Text] [Related]
4. Mouse T lymphocyte response to acetylcholine receptor determined by T cell receptor for antigen V beta gene products recognizing Mls-1a.
Krco CJ; David CS; Lennon VA
J Immunol; 1991 Nov; 147(10):3303-5. PubMed ID: 1834735
[TBL] [Abstract][Full Text] [Related]
5. TCR gene usage in experimental autoimmune myasthenia gravis pathogenesis. Usage of multiple TCRBV genes in the H-2b strains.
Wu B; Shenoy M; Goluszko E; Kaul R; Christadoss P
J Immunol; 1995 Apr; 154(7):3603-10. PubMed ID: 7897239
[TBL] [Abstract][Full Text] [Related]
6. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
Atassi MZ; Oshima M; Deitiker P
Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
[TBL] [Abstract][Full Text] [Related]
7. Experimental autoimmune myasthenia gravis in B10.BV8S2 transgenic mice: preferential usage of TCRAV1 gene by lymphocytes responding to acetylcholine receptor.
Kaul R; Wu B; Goluszko E; Deng C; Dedhia V; Nabozny GH; David CS; Rimm IJ; Shenoy M; Haqqi TM; Christadoss P
J Immunol; 1997 Jun; 158(12):6006-12. PubMed ID: 9190955
[TBL] [Abstract][Full Text] [Related]
8. The influence of self-MHC and non-MHC antigens on the selection of an antigen-specific T cell receptor repertoire.
Fry AM; Cotterman MM; Matis LA
J Immunol; 1989 Oct; 143(8):2723-9. PubMed ID: 2477456
[TBL] [Abstract][Full Text] [Related]
9. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
10. T cell receptor expression and differential proliferative responses by T cells specific to a myasthenogenic peptide.
Kirshner SL; Waisman A; Zisman E; Ben-Nun A; Mozes E
Cell Immunol; 1997 Aug; 180(1):20-8. PubMed ID: 9316635
[TBL] [Abstract][Full Text] [Related]
11. Role of Mls-1 locus and clonal deletion of T cells in susceptibility to collagen-induced arthritis in mice.
Anderson GD; Banerjee S; Luthra HS; David CS
J Immunol; 1991 Aug; 147(4):1189-93. PubMed ID: 1907992
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides.
Atassi MZ; Oshima M
Crit Rev Immunol; 1997; 17(5-6):481-95. PubMed ID: 9419435
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Mlsf system. I. A novel "polymorphism" of endogenous superantigens.
Abe R; Foo-Phillips M; Granger LG; Kanagawa O
J Immunol; 1992 Dec; 149(11):3429-39. PubMed ID: 1331235
[TBL] [Abstract][Full Text] [Related]
14. Effect of amino acid substitutions within the region 62-76 of I-A beta b on binding with and antigen presentation of Torpedo acetylcholine receptor alpha-chain peptide 146-162.
Oshima M; Atassi MZ
J Immunol; 1995 May; 154(10):5245-54. PubMed ID: 7537303
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of self-reactive T cell receptor V beta regions in autoimmune mice.
Mountz JD; Smith TM; Toth KS
J Immunol; 1990 Mar; 144(6):2159-66. PubMed ID: 1690237
[TBL] [Abstract][Full Text] [Related]
16. Influence of the T cell receptor alpha-chain on T cell reactivity and tolerance to Mls-1 in T cell receptor beta-chain transgenic mice.
Blackman MA; Smith HP; Le P; Woodland DL
J Immunol; 1993 Jul; 151(2):556-65. PubMed ID: 8335899
[TBL] [Abstract][Full Text] [Related]
17. Factors that determine the severity of experimental myasthenia gravis.
Drachman DB; McIntosh KR; Yang B
Ann N Y Acad Sci; 1998 May; 841():262-82. PubMed ID: 9668247
[TBL] [Abstract][Full Text] [Related]
18. TCR V beta usage by acetylcholine receptor-specific CD4+ T cells in myasthenia gravis.
Raju R; Navaneetham D; Protti MP; Horton RM; Hoppe BL; Howard J; Conti-Fine BM
J Autoimmun; 1997 Apr; 10(2):203-17. PubMed ID: 9185882
[TBL] [Abstract][Full Text] [Related]
19. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors.
Bellone M; Ostlie N; Lei S; Conti-Tronconi BM
Eur J Immunol; 1991 Oct; 21(10):2303-10. PubMed ID: 1680694
[TBL] [Abstract][Full Text] [Related]
20. CD3+4-8- alpha beta T cell population with biased T cell receptor V gene usage. Presence in bone marrow and possible involvement of IL-3 for their extrathymic development.
Kubota H; Okazaki H; Onuma M; Kano S; Hattori M; Minato N
J Immunol; 1992 Aug; 149(4):1143-50. PubMed ID: 1323608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
